UPDATE

VENKYS NOW TRADING ABOVE 1320

NOW UP

17%

1343

20% circuit candidate told when was only 10% UP

WE TOLD & SEE ITS COMMING

VENKYS LOCKED IN 20% UC

1373

Enjoy 20% MOVE

TVSSHRI

SL Hits..

Exited.

Just Remember 1 Thing.

SL is a Part of this Game.

So do not hesitate to get out when SL Point hits..

HAL

BLAST

💥💣

ONE MORE STOCK 20% UC

HAL

1318

955 TO 1318 DONE TILL NOW

POSITIONAL CAN TEST # 1500/1750

SHORT TERM BOOK PROFITS OR TRAIL AS PER RISK

DEEPAK NITRITE – Q1-FY21 CONFERENCE UPDATE & MANAGEMENT COMMENTRY

• Operated little less than 2 months in Q1.

• DASDA & OBA prices have normalised now – as the plant issues in china have stabilised and the demand from the final segments (paper etc) was also low.

• 65% capacity utilization for the quarter.

• Many players are looking to move away from China – this has helped us in strengthening our market position.

• Deepak Phenolics re-opened in early May. Domestically the demand and prices of phenol has reduced, so we increased our exports.

• We opened IPA this quarter (30 KT) commissioned by our own team. Already been ramped up to 110% of its capacity.

• IPA & Acetone saw a strong pull by Pharma.

• Export- 18% degrowth.

• Expanding IPA to 60 KT – fasttrack manner, to be completed in the next 9 months. A large co-gen power plant expansion to be completed as well

• Basic Chem (43%) – 32% degrowth, Fine & Spl (40%) – Grew by 21%, Perf Chem (17%) -76% contraction

• We are using 30% of phenol captively, the expansion of IPA will increase this to 60%

• Fine and Spl Chem – is doing well, demand is growing for agro and pharma and margins are better. Depreciating rupee is also helping us

• Domestic margins are better than export margins in phenol. But the demand was weak this quarter domestically, so we exported. Running at 100%. EBITDA was 80-85 cr

• Brownfield capacity expansion in phenolics in Q3 & Q4 – IPA & Cogen (only improve bottom line)

• Deepak N brownfield expansion – agro chem intermediates, intermediates going into pharma or personal care

• Price today is abnormally low – DASDA & OBA. As demand is abnormally low too

• Value added products of Acetone & Phenol – not in line with fine and speciality, but lower

• We look for a payback less than 3 years – then we go ahead and invest. Sometimes 4 years

• Our competitor uses propylene and we use acetone for IPA – IPA from acetone is only viable if you have your own acetone, which is our natural strength

• IPA is exported also – the demand of IPA is 2 lac T, the current capacity is 1 lac Ton in India. There is more than normal headroom

• Acetone to IPA is 1:1

• Capex – 200 cr at DEEPAK NITRITE LTD& 200 cr at DEEPAK PHENOLIC LTD. FY21

• Fine and Spl margins will be between 38-42% mostly, can go upto 45% as well, but 38-42% is a better range

• Expecting an Asset turnover of 2:1, for the capex. With a payback period of 3-3.5 years.

HAL

AGAIN BLASTING

10%💚💚

1423 🎯🎯

930 TO 1423 DONE TILL NOW

BOOK 50% PROFITS OR TRAIL WITH
S/L FOR 1600/1800+

PHARMA CAN START SHOWING SOME STABILITY FROM TODAY

POSSIBLE FROM NEXT WEEK PHARMA STOCKS AGAIN BACK IN ACTION

Lupin

1015

SL 900

T Open

One of the Best Book.

If some 1 wants to read can read during weekend.

🇮🇳THIS INDEPENDENCE DAY 🇮🇳

GIVE FREEDOM TO WORRIES

JOIN OUR FREE TELEGRAM CHANNEL FOR MULTIBAGGER RETURNS.

LINK TO JOIN :

t.me/wealthcreature

OUR LAST 4 MONTHS MULTIBAGGER PICKS RETURNS :

🔸MANGALAM ORGANIC 3⃣4⃣5⃣%

🔸IOL CHEMICALS 3⃣4⃣0⃣%

🔸MASTEK LTD 3⃣3⃣5⃣%

🔸VISAKA INDS 2⃣8⃣5⃣%

🔸AARTI DRUGS 2⃣3⃣0⃣%

🔸MORE THAN 20 STOCKS
GIVING 1⃣0⃣0⃣% PLUS RETURNS